中国继续医学教育
中國繼續醫學教育
중국계속의학교육
CHINA CONTINUING MEDICAL EDUCATION
2015年
19期
143-144
,共2页
阿司匹林%冠心病
阿司匹林%冠心病
아사필림%관심병
Aspirin%Coronary heart disease
目的：探析不同剂量阿司匹林抗血小板治疗老年冠心病的有效性和安全性。方法将我院收治的冠心病患者100例分为4组，对比分析4组的治疗效果。结果服用阿司匹林3组的血小板聚集抑制效果优于对照组，P＜0.05，差异具有统计学意义。结论临床上运用阿司匹林治疗老年冠心病，控制好剂量，可以提高治疗的有效性和安全性。
目的：探析不同劑量阿司匹林抗血小闆治療老年冠心病的有效性和安全性。方法將我院收治的冠心病患者100例分為4組，對比分析4組的治療效果。結果服用阿司匹林3組的血小闆聚集抑製效果優于對照組，P＜0.05，差異具有統計學意義。結論臨床上運用阿司匹林治療老年冠心病，控製好劑量，可以提高治療的有效性和安全性。
목적：탐석불동제량아사필림항혈소판치료노년관심병적유효성화안전성。방법장아원수치적관심병환자100례분위4조，대비분석4조적치료효과。결과복용아사필림3조적혈소판취집억제효과우우대조조，P＜0.05，차이구유통계학의의。결론림상상운용아사필림치료노년관심병，공제호제량，가이제고치료적유효성화안전성。
Objective To explore the safety and effective on Different doses of aspirin antiplatelet treatment of senile coronary heart disease. Methods Selected 100 cases with coronary heart disease in our hospital were divided into four groups, the therapeutic effect of comparative analyzed of four groups. Results Aspirin and platelet aggregation inhibition effect of three group was superior to control group, P<0.05, had difference statistically significance. Conclusion The clinical use of aspirin treatment of senile coronary heart disease, control the dose, can improve the efifcacy and safety of treatment.
